Today: 21 April 2026
XRP Price Today: XRP Hovers Near $1.38 After Ripple’s Australia License Move, With CPI Looming
11 March 2026
1 min read

XRP Price Today: XRP Hovers Near $1.38 After Ripple’s Australia License Move, With CPI Looming

SYDNEY, March 11, 2026, 20:27 (UTC+11:00)

XRP hovered near $1.38 Wednesday, slipping back after hitting $1.44 earlier as market players reacted to Ripple’s push for an Australian financial services license and braced for upcoming U.S. inflation figures. The token lingered close to session lows.

All eyes now turn to the U.S. consumer price index—a key inflation indicator that can jolt interest-rate bets and shake up demand for riskier assets, including crypto. Reuters’ latest survey puts forecasts at a 0.3% uptick in February for headline CPI, with core CPI, which ignores food and energy, seen advancing 0.2%. Oil prices slipped, meanwhile, following news that the International Energy Agency suggested its largest-ever emergency stock release.

Ripple plans to secure the Australian Financial Services License by acquiring BC Payments Australia. “Licensing is fundamental to Ripple’s strategy,” said Fiona Murray, managing director for Asia Pacific, who described Australia as “a key market” for Ripple’s push into cross-border payments. The company reported that Asia-Pacific payments volume nearly doubled in 2025, and it now counts over 75 regulatory licenses worldwide. Ripple

XRP wasn’t the only one under pressure. Bitcoin hovered near $69,548 and ether slipped to about $2,019—both down on the day—as the broader crypto market pulled back, erasing a chunk of Tuesday’s relief rally.

Oil prices staged a dramatic turnaround earlier, with Brent and U.S. crude both sinking over 11% on Tuesday, according to Reuters, after President Donald Trump indicated the Middle East conflict might wrap up soon. Risk appetite came back into the market. Barron’s noted XRP was up roughly 1.2% as bitcoin popped back above $70,000.

One more twist: XRP Ledger transactions hit 2.7 million, per CoinDesk, yet the token’s price barely budged. Rising on-chain activity hasn’t pushed XRP out of its range just yet.

Still, the situation looks fragile. Chris Weston at Pepperstone described traders as “largely sitting on their hands.” Kristina Clifton, a strategist at Commonwealth Bank, thinks the war “will run for months, not weeks.” Another jump in CPI or a surge in oil prices could pressure crypto again, and CoinDesk noted that traders are eyeing support close to $1.34. Reuters

XRP isn’t a stock; it’s a digital token. According to a 21Shares filing with the U.S. Securities and Exchange Commission, holding XRP doesn’t grant investors a cut of profits or any income payouts. Ripple, on its end, points to XRP’s role in powering elements of its payments, liquidity, and treasury services. That dynamic puts the focus squarely on regulation, fund flows, and network usage—not earnings.

Stock Market Today

  • MSFT May 6th Options Launch Highlights Attractive Put and Call Opportunities
    April 21, 2026, 11:38 AM EDT. Microsoft Corporation (MSFT) options with May 6th expiration began trading Thursday. Investors can sell-to-open a $295 strike put for $8.45 premium, effectively paying $286.55 per share, about 2% below the current $299.69 price, with a 99% chance it expires worthless, yielding a potential 2.86% return or 24.31% annualized. On the call side, selling a $310 strike covered call offers a $6.20 premium, translating to a 5.51% return if called away. These options reveal strategic entry and income plays amid MSFT's recent twelve-month trading range, offering investors ways to generate yield or define selling prices while managing risk around current share price levels.

Latest article

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

Eli Lilly to Buy Kelonia for Up to $7 Billion as In Vivo CAR-T Gains Ground

21 April 2026
Eli Lilly will acquire Boston-based Kelonia Therapeutics for up to $7 billion in cash, including $3.25 billion upfront, to expand into in vivo CAR-T cancer therapies. Kelonia’s KLN-1010, in Phase 1 for multiple myeloma, generates engineered T-cells inside the patient. The deal marks Lilly’s third Massachusetts biotech purchase in 2026. Kelonia had 62 employees and nearly ran out of cash before the offer.
POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

POET Technologies Stock Soars Again as PFIC Tax Clarity Eases Short-Seller Fears

21 April 2026
POET Technologies shares surged 20% Tuesday, following an 18% gain Monday, after the company addressed U.S. shareholder tax concerns and announced plans to redomicile. Nearly 32.9 million shares traded by 10:21 a.m. ET, with the stock reaching $11.07 before settling at $10.34. Wolfpack Research disclosed a short position last week, sparking volatility. CFO Thomas Mika said POET expects not to qualify as a PFIC in 2026.
Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

Why Rocket Lab Stock Is Rising Again as Analysts Lift Targets and Golden Dome Spending Comes Into Focus

21 April 2026
Rocket Lab shares rose 2% to $91.12 Tuesday after analysts raised price targets and the Pentagon detailed new space defense spending in its 2027 budget request. The company closed its $155 million Mynaric acquisition last week and reported a $190 million Pentagon launch contract in March, bringing its backlog above $2 billion. Rocket Lab now expects to launch its Neutron rocket in late 2026 after a test setback.
Denison Mines Corp starts Wheeler North drilling as Phoenix uranium mine build nears
Previous Story

Denison Mines Corp starts Wheeler North drilling as Phoenix uranium mine build nears

USD/EUR Price Today: Dollar Holds Near 0.86 Euro as Oil Shock, U.S. CPI Box In Traders
Next Story

USD/EUR Price Today: Dollar Holds Near 0.86 Euro as Oil Shock, U.S. CPI Box In Traders

Go toTop